Literature DB >> 12973857

Combination of early bisphosphonate administration and irradiation leads to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model.

Robert Krempien1, Peter E Huber, Wolfgang Harms, Martina Treiber, Michael Wannenmacher, Burkhardt Krempien.   

Abstract

BACKGROUND: The goal of the current study was to analyze the combined effect of bisphosphonates (BPs) and irradiation on remineralization and restabilization of osteolytic bone metastases in an animal tumor model.
METHODS: Bone metastases were induced in male Wistar rats via intraosseous injection of the Walker carcinosarcoma 256B cell line into both proximal tibia metaphyses on Day 1 of the study. Three treatment groups were analyzed. All animals received a single radiation dose of 17 grays (in the form of 6-megaelectron-volt electrons) on Day 7 and were sacrificed on Day 49. Group 1 (the control group) was treated with irradiation only. Groups 2 and 3 received additional BPs (clodronate; daily intraperitoneal injection dose, 20 mg/kg per day). In Group 2, BPs were given before irradiation, on Days 3-6; this schedule later was referred to as early BP treatment. In Group 3, BPs were administered simultaneously with irradiation, on Days 7-10; this schedule later was referred to as simultaneous BP treatment. The endpoints of the study were bone density and microstructural parameters of bone on Day 49. Bone density was measured using X-ray absorption. Microstructural parameters of bone were assessed using histomorphometry. A total of thirty tibiae were analyzed in each group.
RESULTS: After irradiation, bone density was significantly higher among animals in the early BP treatment group compared with those in the control group and those in the simultaneous BP treatment group (P = 0.001). Histomorphometric analysis of bone showed significantly better-preserved (P < 0.001) microstructural parameters (bone area, trabecular number, and trabecular separation) in the early BP treatment group compared with the control and simultaneous BP treatment groups.
CONCLUSIONS: Early BP administration in combination with irradiation led to improved remineralization and restabilization of osteolytic bone metastases in an animal tumor model. Copyright 2003 American Cancer Society.DOI 10.1002/cncr.11646

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12973857     DOI: 10.1002/cncr.11646

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  7 in total

1.  Sequence- and concentration-dependent effects of acute and long-term exposure to the bisphosphonate ibandronate in combination with single and multiple fractions of ionising radiation doses in human breast cancer cell lines.

Authors:  Fabrice Journé; Nicolas Magné; Carole Chaboteaux; Eric Kinnaert; Frieder Bauss; Jean-Jacques Body
Journal:  Clin Exp Metastasis       Date:  2006-08-16       Impact factor: 5.150

2.  Effects of zoledronate on the radiation-induced collagen breakdown: a prospective randomized clinical trial.

Authors:  M Gierloff; M Reutemann; A Gülses; P Niehoff; J Wiltfang; Y Açil
Journal:  Clin Transl Oncol       Date:  2014-11-26       Impact factor: 3.405

Review 3.  Rat models of bone metastases.

Authors:  Stéphane Blouin; Michel Félix Baslé; Daniel Chappard
Journal:  Clin Exp Metastasis       Date:  2006-05-03       Impact factor: 5.150

Review 4.  Bisphosphonate treatment and radiotherapy in metastatic breast cancer.

Authors:  A Ugur Ural; Ferit Avcu; Yusuf Baran
Journal:  Med Oncol       Date:  2008-01-17       Impact factor: 3.064

5.  Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.

Authors:  Robert Foerster; Christian Eisele; Thomas Bruckner; Tilman Bostel; Ingmar Schlampp; Robert Wolf; Juergen Debus; Harald Rief
Journal:  Radiat Oncol       Date:  2015-03-07       Impact factor: 3.481

Review 6.  Therapeutic Irradiation: Consequences for Bone and Bone Marrow Adipose Tissue.

Authors:  Samantha Costa; Michaela R Reagan
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-29       Impact factor: 5.555

7.  Palliative radiotherapy of bone metastases in octogenarians: How do the oldest olds respond? Results from a tertiary cancer center with 288 treated patients.

Authors:  Alexander Rühle; Verlaine Ange Nya Yompang; Simon K B Spohn; Raluca Stoian; Constantinos Zamboglou; Eleni Gkika; Anca-Ligia Grosu; Nils H Nicolay; Tanja Sprave
Journal:  Radiat Oncol       Date:  2022-09-07       Impact factor: 4.309

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.